2.7(top 20%)
impact factor
447(top 50%)
papers
7.0K(top 20%)
citations
42(top 20%)
h-index
2.8(top 20%)
impact factor
554
all documents
7.9K
doc citations
61(top 20%)
g-index

Top Articles

#TitleJournalYearCitations
1Interferon pathway in SLE: one key to unlocking the mystery of the diseaseLupus Science and Medicine2019194
2Haematological manifestations of lupusLupus Science and Medicine2015174
3A proteinuria cut-off level of 0.7 g/day after 12 months of treatment best predicts long-term renal outcome in lupus nephritis: data from the MAINTAIN Nephritis TrialLupus Science and Medicine2015155
4Effect of corticosteroid use by dose on the risk of developing organ damage over time in systemic lupus erythematosus--the Hopkins Lupus CohortLupus Science and Medicine2015140
5Lupus anticoagulant is the main predictor of adverse pregnancy outcomes in aPL-positive patients: validation of PROMISSE study resultsLupus Science and Medicine2016118
6Mouse models of lupus: what they tell us and what they don’tLupus Science and Medicine2018112
7Association of the interferon signature metric with serological disease manifestations but not global activity scores in multiple cohorts of patients with SLELupus Science and Medicine2015103
8Response to belimumab among patients with systemic lupus erythematosus in clinical practice settings: 24-month results from the OBSErve study in the USALupus Science and Medicine201698
92021 DORIS definition of remission in SLE: final recommendations from an international task forceLupus Science and Medicine202197
10Role of early repeated renal biopsies in lupus nephritisLupus Science and Medicine201496
11Type I interferons in host defence and inflammatory diseasesLupus Science and Medicine201991
12Characterisation of anifrolumab, a fully human anti-interferon receptor antagonist antibody for the treatment of systemic lupus erythematosusLupus Science and Medicine201887
13DNA methylation patterns in naïve CD4+ T cells identify epigenetic susceptibility loci for malar rash and discoid rash in systemic lupus erythematosusLupus Science and Medicine201583
14Early proteinuria response: a valid real-life situation predictor of long-term lupus renal outcome in an ethnically diverse group with severe biopsy-proven nephritis?Lupus Science and Medicine201782
15Current and future therapies for SLE: obstacles and recommendations for the development of novel treatmentsLupus Science and Medicine201782
16Placental histology and neutrophil extracellular traps in lupus and pre-eclampsia pregnanciesLupus Science and Medicine201678
17Independent association of glucocorticoids with damage accrual in SLELupus Science and Medicine201677
18TNF-α and plasma albumin as biomarkers of disease activity in systemic lupus erythematosusLupus Science and Medicine201873
19Association of low vitamin D with high disease activity in an Australian systemic lupus erythematosus cohortLupus Science and Medicine201570
20Cell-bound complement activation products in systemic lupus erythematosus: comparison with anti-double-stranded DNA and standard complement measurementsLupus Science and Medicine201465
21Clinical, laboratory and health-related quality of life correlates of Systemic Lupus Erythematosus Responder Index response: a post hoc analysis of the phase 3 belimumab trialsLupus Science and Medicine201463
22Lupus community panel proposals for optimising clinical trials: 2018Lupus Science and Medicine201862
23Disease activity patterns over time in patients with SLE: analysis of the Hopkins Lupus CohortLupus Science and Medicine201761
24Risk factors for osteoporosis and fragility fractures in patients with systemic lupus erythematosusLupus Science and Medicine201660
25Systemic lupus erythematosus complicated by diffuse alveolar haemorrhage: risk factors, therapy and survivalLupus Science and Medicine201559
26Remission and low disease activity in systemic lupus erythematosus: an achievable goal even with fewer steroids? Real-life data from a monocentric cohortLupus Science and Medicine201859
27Inducible T-cell co-stimulator ligand (ICOSL) blockade leads to selective inhibition of anti-KLH IgG responses in subjects with systemic lupus erythematosusLupus Science and Medicine201657
28Which outcome measures in SLE clinical trials best reflect medical judgment?Lupus Science and Medicine201456
2910 most important contemporary challenges in the management of SLELupus Science and Medicine201955
30Lower vitamin D levels are associated with higher systemic lupus erythematosus activity, but not predictive of disease flare-upLupus Science and Medicine201454
31Genome-wide profiling identifies associations between lupus nephritis and differential methylation of genes regulating tissue hypoxia and type 1 interferon responsesLupus Science and Medicine201654
32Targeting mitochondrial oxidative stress with MitoQ reduces NET formation and kidney disease in lupus-prone MRL-lprmiceLupus Science and Medicine202054
33Prediction of prognosis and renal outcome in lupus nephritisLupus Science and Medicine202053
34DNA methylation 101: what is important to know about DNA methylation and its role in SLE risk and disease heterogeneityLupus Science and Medicine201852
35Off-label use of rituximab for systemic lupus erythematosus in EuropeLupus Science and Medicine201651
36Anifrolumab effects on rash and arthritis: impact of the type I interferon gene signature in the phase IIb MUSE study in patients with systemic lupus erythematosusLupus Science and Medicine201851
37Kynurenine pathway is altered in patients with SLE and associated with severe fatigueLupus Science and Medicine201851
38Type I interferon receptor blockade with anifrolumab corrects innate and adaptive immune perturbations of SLELupus Science and Medicine201851
39Cardiovascular events prior to or early after diagnosis of systemic lupus erythematosus in the systemic lupus international collaborating clinics cohortLupus Science and Medicine201650
40Safety, pharmacokinetics and pharmacodynamics of AMG 811, an anti-interferon-γ monoclonal antibody, in SLE subjects without or with lupus nephritisLupus Science and Medicine201749
41Lupus anticoagulant, disease activity and low complement in the first trimester are predictive of pregnancy lossLupus Science and Medicine201548
42Interferon (IFN)-λ is a potential mediator in lupus nephritisLupus Science and Medicine201648
43Work disability, lost productivity and associated risk factors in patients diagnosed with systemic lupus erythematosusLupus Science and Medicine201547
44Associates and predictors of pleurisy or pericarditis in SLELupus Science and Medicine201746
45Safety and efficacy of hCDR1 (Edratide) in patients with active systemic lupus erythematosus: results of phase II studyLupus Science and Medicine201545
46Safety profile of anifrolumab in patients with active SLE: an integrated analysis of phase II and III trialsLupus Science and Medicine202145
47Presentation of SLE in UK primary care using the Clinical Practice Research DatalinkLupus Science and Medicine201742
48Obstetric antiphospholipid syndromeLupus Science and Medicine201842
49Reduced response to Epstein–Barr virus antigens by T-cells in systemic lupus erythematosus patientsLupus Science and Medicine201441
50I too, am America: a review of research on systemic lupus erythematosus in African-AmericansLupus Science and Medicine201641